StudyFinder

Expanded Access of Obinutuzumab in a Patient Who Responded to Treatment While on a Clinical Trial

Status: OPEN TO ACCRUAL

I'm interested

Age:

Healthy Volunteers:

Interventions:

drug: Obinutuzumab, Modality: Chemotherapy (nos)

Conditions:

Non-Hodgkin's Lymphoma

Contact(s): ctrrecruit@vcu.edu

Principal Investigator: Yazbeck, Victor, Y

Phase: N/A

IRB Number: HM20015975

System ID: 14756

Back